Analysis Group Health Care Consultants Present at the Alzheimer's Association International Conference 2017
July 27, 2017
An Analysis Group team led by Vice President Noam Kirson and Manager Urvi Desai coauthored two presentations at this year's Alzheimer's Association International Conference, which took place in London from July 16-20. Both studies were conducted in collaboration with Eli Lilly and Company.
An oral presentation, "Trends in Health Service Use and Potentially Avoidable Hospitalizations Prior to Alzheimer's Disease Diagnosis: A Matched, Retrospective Study of US Medicare Beneficiaries," compared medical resource use of 19,679 pairs of elderly people with and without Alzheimer's disease (AD). The study found that in the three years prior to diagnosis, people with AD had substantially higher – and increasing – rates of hospitalizations, emergency room visits, and falls compared to those with no AD diagnosis. The study also found that 30-40% of the hospitalizations could potentially be prevented with better routine care. These findings suggest that early identification of AD could help people with the disease, their caregivers, and their doctors manage the condition more effectively, and reduce unnecessary medical resource use.
In addition to the oral presentation, Dr. Kirson and Dr. Desai presented a poster, "Is the Annual Wellness Visit Adequate to Impact Cognitive Care?" in collaboration with researchers from the Indiana University Center for Aging Research. One goal of the Medicare Annual Wellness Visit (AWV) is to detect possible cognitive impairment and, if found, facilitate further diagnostic evaluation and care planning. In this study, however, the research team found no differences in the frequencies with which elderly people with and without an AWV received a diagnosis or medication for cognitive impairment in the following year. Standardizing how cognitive impairment is assessed in the AWV and how providers organize subsequent care are important areas for future research to improve the detection and management of early cognitive impairment.
Learn more about the AAIC 2017 conference
Read Eli Lilly's news release about its presentations at the conference